Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

BA-BE Studies: SOP for Analyst Training on LC-MS/MS Operation – V 2.0

Posted on By

BA-BE Studies: SOP for Analyst Training on LC-MS/MS Operation – V 2.0

Standard Operating Procedure for Analyst Training on LC-MS/MS Operation in BA/BE Studies

Department BA-BE Studies
SOP No. SOP/BA-BE/167/2025
Supersedes SOP/BA-BE/167/2022
Page No. Page 1 of 11
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To establish a structured and compliant training program for analysts on the operation, maintenance, and troubleshooting of LC-MS/MS instruments used in bioanalytical studies for BA/BE projects.

2. Scope

This SOP applies to all analysts involved in operating LC-MS/MS systems (e.g., Sciex, Agilent, Waters) for plasma sample analysis in bioequivalence and bioavailability studies at the bioanalytical laboratory.

3. Responsibilities

  • Training Coordinator: Schedules
training, assigns mentors, maintains training logs.
  • Qualified Analyst (Trainer): Provides hands-on instrument training and evaluates trainee competency.
  • Trainee Analyst: Attends sessions, performs tasks under supervision, and completes evaluation modules.
  • QA Unit: Reviews training documentation and ensures adherence to training matrix.
  • 4. Accountability

    The Head of Bioanalytical Department is accountable for ensuring training is completed, assessed, and documented prior to analyst authorization on LC-MS/MS instruments.

    5. Procedure

    5.1 Training Enrollment and Planning

    1. New analysts or analysts assigned to a new LC-MS/MS platform must be enrolled in training via Annexure-1: Training Request Form.
    2. Assign a qualified mentor who has minimum 6 months hands-on experience with the instrument.
    3. Define training timeline (typically 4–6 weeks) and topics in accordance with the Training Curriculum.

    5.2 Training Curriculum

    1. The training program shall include modules on:
      • System start-up and shutdown procedures
      • Instrument calibration and tuning
      • Sample loading and sequence creation
      • Data acquisition and processing
      • Manual integration and data review
      • Routine maintenance and troubleshooting
      • Audit trail review and data backup
    2. The trainee shall perform all steps under direct observation of the mentor initially, followed by supervised repetition.

    5.3 Evaluation of Competency

    1. Upon completion, the mentor shall conduct a theoretical and practical assessment using Annexure-2: Training Evaluation Checklist.
    2. Analyst must demonstrate:
      • Fluent software navigation (e.g., Analyst, MassLynx)
      • Accurate sequence setup and sample ID management
      • Troubleshooting for pressure drops, signal loss, or communication errors

    5.4 Documentation

    1. All training steps shall be recorded and signed in Annexure-3: Training Record Sheet.
    2. Assessment scores and trainer recommendations must be recorded.
    3. Analyst shall not operate instrument independently until certified in Annexure-4: Certificate of Completion.

    5.5 Refresher and Cross-Training

    1. Annual refresher training is mandatory or in case of:
      • Major software upgrades
      • Instrument model change
      • Extended absence (>3 months)
    2. Cross-training to other LC-MS/MS platforms must follow this SOP again.

    6. Abbreviations

    • BA/BE: Bioavailability/Bioequivalence
    • LC-MS/MS: Liquid Chromatography-Tandem Mass Spectrometry
    • QA: Quality Assurance
    • SOP: Standard Operating Procedure

    7. Documents

    1. Training Request Form – Annexure-1
    2. Training Evaluation Checklist – Annexure-2
    3. Training Record Sheet – Annexure-3
    4. Certificate of Completion – Annexure-4

    8. References

    • ICH M10: Bioanalytical Method Validation
    • FDA Guidance on Bioanalytical Method Validation
    • Internal Bioanalytical Training Policy

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Training Request Form

    Request Date 15/04/2025
    Analyst Name Sunita Reddy
    Instrument Assigned Sciex QTRAP 6500+
    Trainer Assigned Rajesh Kumar

    Annexure-2: Training Evaluation Checklist

    Module Status Comments
    System Start/Stop Completed Clear understanding
    Tuning Completed Proficient
    Sequence Setup Completed Accurate

    Annexure-3: Training Record Sheet

    Date Activity Performed By Trainer Initials
    10/04/2025 Demo: LC pump setup Sunita Reddy RK
    12/04/2025 Sample injection and acquisition Sunita Reddy RK

    Annexure-4: Certificate of Completion

    This certifies that Sunita Reddy has successfully completed training on Sciex QTRAP 6500+ LC-MS/MS system and is authorized to independently operate the instrument for routine bioanalytical work.

    Date of Completion: 17/04/2025
    Authorized By: Head – Bioanalytical Department

    Revision History:

    Revision Date Revision No. Details Reason Approved By
    01/01/2022 1.0 Initial issue New SOP QA Head
    17/04/2025 2.0 Added evaluation and certification steps Compliance with ICH M10 QA Head
    See also  BA-BE Studies: SOP for Environmental Monitoring in Volunteer Areas - V 2.0
    BA-BE Studies V 2.0 Tags:Absolute bioavailability, AUC (area under the curve), Bioavailability, Bioequivalence, Bioequivalence criteria, CDSCO bioequivalence norms, Clinical trial registration, Cmax (maximum concentration), Confidence interval %, Crossover study design, EMA bioequivalence requirements, Ethics committee approval, FDA bioequivalence guidelines, Generic drug approval, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Half-life (t½), ICH E(R) compliance, In vitro dissolution, In vivo studies, Informed consent process, Pharmacodynamics, Pharmacokinetics, Randomized controlled trial, Regulatory submission process, Relative bioavailability, Sample size calculation, Therapeutic equivalence, Tmax (time to maximum concentration), Washout period

    Post navigation

    Previous Post: Aerosol: SOP for Conducting Training for Aerosol Manufacturing Staff – V 2.0
    Next Post: API Manufacturing: SOP for Daily Environmental Monitoring in QC Lab – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2026 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version